Theodora Agalioti

Theodora Agalioti

Auto-generated profile, based on publicly available information

Theodora Agalioti

Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2000 in Cell
Verified
Journal Article
Open access
TATheodora Agalioti
Theodora Agalioti
SLStavros Lomvardas
Stavros Lomvardas
BPBhavin Parekh
Bhavin Parekh
JYJunming Yie
Junming Yie
TMTom Maniatis
Tom Maniatis
DTDimitris Thanos
Dimitris Thanos
Here, we show that the IFN-beta enhanceosome activates transcription by directing the ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. The enhanceosome is assembled in the nucleosome-free enhancer region of the IFN-beta gene, leading to the modification and remodeling of a strategically positioned nucleosome that masks the TATA box and the start site of transcription. Initially, the GCN5 complex is recruited, which acetylates the nucleosome, and this is followed by recruitment of the CBP-PolII holoenzyme complex. Nucleosome acetylation in turn facilitates SWI/SNF recruitment by CBP, resulting in chromatin remodeling. This program of recruitment culminates in the binding of TFIID to the promoter and the activation of transcription.

1 November 2002 in Cell
Verified
Journal Article
Closed access
TATheodora Agalioti
Theodora Agalioti
GCGuoying Chen
Guoying Chen
DTDimitris Thanos
Dimitris Thanos

10 August 2001 in Science
Verified
Journal Article
Closed access
PDF file
NMNikhil Munshi
Nikhil Munshi
TATheodora Agalioti
Theodora Agalioti
SLStavros Lomvardas
Stavros Lomvardas
MMMenie Merika
Menie Merika
GCGuoying Chen
Guoying Chen
DTDimitris Thanos
Dimitris Thanos
Dynamic control of interferon-β (IFN-β) gene expression requires the regulated assembly and disassembly of the enhanceosome, a higher-order nucleoprotein complex formed in response to virus infection. The enhanceosome activates transcription by recruiting the histone acetyltransferase proteins CREB binding protein (CBP) and p 300/ C BP- a ssociated f actors (PCAF)/GCN5, which, in addition to modifying histones, acetylate HMGI(Y), the architectural component required for enhanceosome assembly. We show that the accurate execution of the IFN-β transcriptional switch depends on the ordered acetylation of the high-mobility group I protein HMGI(Y) by PCAF/GCN5 and CBP, which acetylate HMGI(Y) at distinct lysine residues on endogenous promoters. Whereas acetylation of HMGI(Y) by CBP at lysine-65 destabilizes the enhanceosome, acetylation of HMGI(Y) by PCAF/GCN5 at lysine-71 potentiates transcription by stabilizing the enhanceosome and preventing acetylation by CBP.

15 October 2000 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
DODavid W. O'Neill
David W. O'Neill
SSStuti S. Schoetz
Stuti S. Schoetz
RLRocio A. Lopez
Rocio A. Lopez
MCMadalyn Castle
Madalyn Castle
LRLisa Rabinowitz
Lisa Rabinowitz
ABArthur Bank
Arthur Bank
We have previously described a SWI/SNF-related protein complex (PYR complex) that is restricted to definitive (adult-type) hematopoietic cells and that specifically binds DNA sequences containing long stretches of pyrimidines. Deletion of an intergenic DNA-binding site for this complex from a human β-globin locus construct results in delayed human γ- to β-globin switching in transgenic mice, suggesting that the PYR complex acts to facilitate the switch. We now show that PYR complex DNA-binding activity also copurifies with subunits of a second type of chromatin-remodeling complex, nucleosome-remodeling deacetylase (NuRD), that has been shown to have both nucleosome-remodeling and histone deacetylase activities. Gel supershift assays using antibodies to the ATPase-helicase subunit of the NuRD complex, Mi-2 (CHD4), confirm that Mi-2 is a component of the PYR complex. In addition, we show that the hematopoietic cell-restricted zinc finger protein Ikaros copurifies with PYR complex DNA-binding activity and that antibodies to Ikaros also supershift the complex. We also show that NuRD and SWI/SNF components coimmunopurify with each other as well as with Ikaros. Competition gel shift experiments using partially purified PYR complex and recombinant Ikaros protein indicate that Ikaros functions as a DNA-binding subunit of the PYR complex. Our results suggest that Ikaros targets two types of chromatin-remodeling factors—activators (SWI/SNF) and repressors (NuRD)—in a single complex (PYR complex) to the β-globin locus in adult erythroid cells. At the time of the switch from fetal to adult globin production, the PYR complex is assembled and may function to repress γ-globin gene expression and facilitate γ- to β-globin switching.

1 November 1998 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
Androniki KretsovaliAndroniki Kretsovali
Androniki Kretsovali
TATheodora Agalioti
Theodora Agalioti
Charalampos SpilianakisCharalampos Spilianakis
Charalampos Spilianakis
ETEleni Tzortzakaki
Eleni Tzortzakaki
MMMenie Merika
Menie Merika
JPJoseph Papamatheakis
Joseph Papamatheakis
The class II transactivator (CIITA) is a key regulatory factor that controls expression of the major histocompatibility complex (MHC) class II genes that are essential components for antigen presentation and thus regulation of the immune response. We show here that the adenovirus E1A protein interferes with the action of CIITA and inhibits both B-cell-specific and gamma interferon (IFN-γ)-induced expression of MHC class II promoters. Transfection studies provide evidence for the functional role of the CREB-binding protein (CBP) in IFN-γ and CIITA-mediated MHC class II promoter activation. We demonstrate that the N-terminally located transcription activation domain of CIITA physically interacts with both the N-terminal and the E1A-binding (C/H3) regions of CBP. These results suggest the involvement of a multisubunit complex, which contains the gene-specific coactivator CIITA and the versatile coactivator CBP, in MHC class II gene regulation, which may be responsible for both high-level expression and modulation by different signaling pathways.

21 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
LBLeonie Brockmann
Leonie Brockmann
SSShiwa Soukou
Shiwa Soukou
BSBabett Steglich
Babett Steglich
PCPaulo Czarnewski
Paulo Czarnewski
LZLilan Zhao
Lilan Zhao
Samuel HuberSamuel Huber
Samuel Huber
IL-10 is a prototypical anti-inflammatory cytokine, which is fundamental to the maintenance of immune homeostasis, especially in the intestine. There is an assumption that cells producing IL-10 have an immunoregulatory function. However, here we report that IL-10-producing CD4+ T cells are phenotypically and functionally heterogeneous. By combining single cell transcriptome and functional analyses, we identified a subpopulation of IL-10-producing Foxp3neg CD4+ T cells that displays regulatory activity unlike other IL-10-producing CD4+ T cells, which are unexpectedly pro-inflammatory. The combinatorial expression of co-inhibitory receptors is sufficient to discriminate IL-10-producing CD4+ T cells with regulatory function from others and to identify them across different tissues and disease models in mice and humans. These regulatory IL-10-producing Foxp3neg CD4+ T cells have a unique transcriptional program, which goes beyond the regulation of IL-10 expression. Finally, we found that patients with Inflammatory Bowel Disease demonstrate a deficiency in this specific regulatory T-cell subpopulation.